Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Individualized automated planning for dose bath reduction in robotic radiosurgery for benign tumors.

Rossi L, Méndez Romero A, Milder M, de Klerck E, Breedveld S, Heijmen B.

PLoS One. 2019 Feb 6;14(2):e0210279. doi: 10.1371/journal.pone.0210279. eCollection 2019.

2.

Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy - An international multi-center validation for prostate cancer.

Heijmen B, Voet P, Fransen D, Penninkhof J, Milder M, Akhiat H, Bonomo P, Casati M, Georg D, Goldner G, Henry A, Lilley J, Lohr F, Marrazzo L, Pallotta S, Pellegrini R, Seppenwoolde Y, Simontacchi G, Steil V, Stieler F, Wilson S, Breedveld S.

Radiother Oncol. 2018 Aug;128(2):343-348. doi: 10.1016/j.radonc.2018.06.023. Epub 2018 Jun 30.

PMID:
29970259
3.

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Strahlenther Onkol. 2018 Sep;194(9):843-854. doi: 10.1007/s00066-018-1314-2. Epub 2018 May 25.

PMID:
29802435
4.

Robotic stereotactic treatment for malignant metastasis of solid tumour in the pancreas: A multiple case report and review of literature.

Loi M, Magallon-Baro A, Papalazarou C, Milder M, Nuyttens JJ.

Cancer Radiother. 2017 Dec;21(8):784-787. doi: 10.1016/j.canrad.2017.06.012. Epub 2017 Nov 11. Review.

PMID:
29132801
5.

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.

Decraene C, Silveira AB, Bidard FC, Vallée A, Michel M, Melaabi S, Vincent-Salomon A, Saliou A, Houy A, Milder M, Lantz O, Ychou M, Denis MG, Pierga JY, Stern MH, Proudhon C.

Clin Chem. 2018 Feb;64(2):317-328. doi: 10.1373/clinchem.2017.272518. Epub 2017 Nov 9.

6.

A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.

Mobuchon L, Battistella A, Bardel C, Scelo G, Renoud A, Houy A, Cassoux N, Milder M, Cancel-Tassin G, Cussenot O, Delattre O, Besse C, Boland A, Deleuze JF, Cox DG, Stern MH.

NPJ Genom Med. 2017;2. pii: 5. doi: 10.1038/s41525-017-0008-5. Epub 2017 Mar 10.

7.

CyberKnife with integrated CT-on-rails: System description and first clinical application for pancreas SBRT.

Papalazarou C, Klop GJ, Milder MTW, Marijnissen JPA, Gupta V, Heijmen BJM, Nuyttens JJME, Hoogeman MS.

Med Phys. 2017 Sep;44(9):4816-4827. doi: 10.1002/mp.12432. Epub 2017 Aug 2.

PMID:
28657157
8.

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study.

Cabel L, Riva F, Servois V, Livartowski A, Daniel C, Rampanou A, Lantz O, Romano E, Milder M, Buecher B, Piperno-Neumann S, Bernard V, Baulande S, Bieche I, Pierga JY, Proudhon C, Bidard FC.

Ann Oncol. 2017 Aug 1;28(8):1996-2001. doi: 10.1093/annonc/mdx212.

PMID:
28459943
9.

Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Riva F, Bidard FC, Houy A, Saliou A, Madic J, Rampanou A, Hego C, Milder M, Cottu P, Sablin MP, Vincent-Salomon A, Lantz O, Stern MH, Proudhon C, Pierga JY.

Clin Chem. 2017 Mar;63(3):691-699. doi: 10.1373/clinchem.2016.262337. Epub 2017 Jan 10.

10.

Amyloid-like ribbons of amelogenins in enamel mineralization.

Carneiro KM, Zhai H, Zhu L, Horst JA, Sitlin M, Nguyen M, Wagner M, Simpliciano C, Milder M, Chen CL, Ashby P, Bonde J, Li W, Habelitz S.

Sci Rep. 2016 Mar 24;6:23105. doi: 10.1038/srep23105.

11.

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.

Madic J, Kiialainen A, Bidard FC, Birzele F, Ramey G, Leroy Q, Rio Frio T, Vaucher I, Raynal V, Bernard V, Lermine A, Clausen I, Giroud N, Schmucki R, Milder M, Horn C, Spleiss O, Lantz O, Stern MH, Pierga JY, Weisser M, Lebofsky R.

Int J Cancer. 2015 May 1;136(9):2158-65. doi: 10.1002/ijc.29265. Epub 2014 Oct 23.

12.

High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.

Péguillet I, Milder M, Louis D, Vincent-Salomon A, Dorval T, Piperno-Neumann S, Scholl SM, Lantz O.

Cancer Res. 2014 Apr 15;74(8):2204-16. doi: 10.1158/0008-5472.CAN-13-2269. Epub 2014 Feb 17.

13.

Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections.

Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F, Milder M, Louis D, Chiche JD, Mira JP, Lantz O, Pène F.

Intensive Care Med. 2014 Feb;40(2):192-201. doi: 10.1007/s00134-013-3163-x. Epub 2013 Dec 10.

PMID:
24322275
14.

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.

Bidard FC, Madic J, Mariani P, Piperno-Neumann S, Rampanou A, Servois V, Cassoux N, Desjardins L, Milder M, Vaucher I, Pierga JY, Lebofsky R, Stern MH, Lantz O.

Int J Cancer. 2014 Mar 1;134(5):1207-13. doi: 10.1002/ijc.28436. Epub 2013 Sep 3.

15.

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

Madic J, Piperno-Neumann S, Servois V, Rampanou A, Milder M, Trouiller B, Gentien D, Saada S, Assayag F, Thuleau A, Nemati F, Decaudin D, Bidard FC, Desjardins L, Mariani P, Lantz O, Stern MH.

Clin Cancer Res. 2012 Jul 15;18(14):3934-41. doi: 10.1158/1078-0432.CCR-12-0309. Epub 2012 May 29.

16.

Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.

Dusseaux M, Martin E, Serriari N, Péguillet I, Premel V, Louis D, Milder M, Le Bourhis L, Soudais C, Treiner E, Lantz O.

Blood. 2011 Jan 27;117(4):1250-9. doi: 10.1182/blood-2010-08-303339. Epub 2010 Nov 17.

17.

Revisiting the optical properties of the FMO protein.

Milder MT, Brüggemann B, van Grondelle R, Herek JL.

Photosynth Res. 2010 Jun;104(2-3):257-74. doi: 10.1007/s11120-010-9540-1. Epub 2010 Mar 13. Review.

18.

Tunable aggregation and luminescence of bis(diarylethene)sexithiophenes.

Milder MT, Herek JL, Areephong J, Feringa BL, Browne WR.

J Phys Chem A. 2009 Jul 9;113(27):7717-24. doi: 10.1021/jp8113896.

PMID:
19507814
19.

Quantum control experiment reveals solvation-induced decoherence.

van der Walle P, Milder MT, Kuipers L, Herek JL.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):7714-7. doi: 10.1073/pnas.0901833106. Epub 2009 Apr 28.

20.

Photoswitchable sexithiophene-based molecular wires.

Areephong J, Hurenkamp JH, Milder MT, Meetsma A, Herek JL, Browne WR, Feringa BL.

Org Lett. 2009 Feb 5;11(3):721-4. doi: 10.1021/ol8028059.

PMID:
19140721
21.

Comparison between clinician-assisted and fully automated procedures for obtaining a voice range profile.

Titze IR, Wong D, Milder MA, Hensley SR, Ramig LO.

J Speech Hear Res. 1995 Jun;38(3):526-35.

PMID:
7674644
22.

Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.

Salmon SE, Tesh D, Crowley J, Saeed S, Finley P, Milder MS, Hutchins LF, Coltman CA Jr, Bonnet JD, Cheson B, et al.

J Clin Oncol. 1990 Sep;8(9):1575-84.

PMID:
2131793
23.

Idiopathic hemochromatosis, an interim report.

Milder MS, Cook JD, Stray S, Finch CA.

Medicine (Baltimore). 1980 Jan;59(1):34-49. Review.

PMID:
6986008
24.

Influence of food iron absorption on the plasma iron level in idiopathic hemochromatosis.

Milder MS, Cook JD, Finch CA.

Acta Haematol. 1978;60(2):65-75.

PMID:
98952
25.

Cavitating splenic infarction.

Rosenblum AL, Bonner H Jr, Milder MS, Mrenner VJ, Weinstein MA, Cook AJ, Carbone PP.

Am J Med. 1974 May;56(5):720-4. No abstract available.

PMID:
4523790
26.

Letter: Spleen size in SLE.

Milder MS, Aptekar RG, Larson SM, Decker JL, Johnston GS.

Arthritis Rheum. 1974 Mar-Apr;17(2):190-1. No abstract available.

PMID:
4592572
27.

The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies.

Gelrud LG, Arseneau JC, Milder MS, Kramer RJ, Swann SJ, Canellos GP, Johnston GS.

J Lab Clin Med. 1974 Mar;83(3):489-95. No abstract available.

PMID:
4204653
28.

Gallium-67 scintigraphy in malignant melanoma.

Milder MS, Frankel RS, Bulkley GB, Ketcham AS, Johnston GS.

Cancer. 1973 Dec;32(6):1350-6. No abstract available.

PMID:
4757925
29.

67Ga scintigraphy in acute leukemia.

Milder MS, Glick JH, Henderson ES, Johnston GS.

Cancer. 1973 Oct;32(4):803-8. No abstract available.

PMID:
4518587
30.

The gallium-67 scan in clinical assessment of cancer.

Johnston GS, Jones AE, Milder MS, Frankel RL, Kramer RJ, Arseneau JC.

J Surg Oncol. 1973 Jun;5(6):529-38. No abstract available.

PMID:
4520980
31.

Liver-spleen scan in Hodgkin's disease.

Milder MS, Larson SM, Bagley CM Jr, DeVita VT Jr, Johnson RE, Johnston GS.

Cancer. 1973 Apr;31(4):826-34. No abstract available.

PMID:
4706049
32.

Interpretation of the 67 Ga photoscan.

Larson SM, Milder MS, Johnston GS.

J Nucl Med. 1973 Apr;14(4):208-14. No abstract available.

33.

False-positive liver scan due to breast prosthesis.

Milder MS, Larson SM, Swann SJ, Johnston GS.

J Nucl Med. 1973 Mar;14(3):189. No abstract available.

34.

The radioisotopic estimation of regional blood flow, blood volume, and hematocrit in the dog lung.

Milder MS, Lisberg K, Evens RG, Potchen EJ.

J Nucl Med. 1971 May;12(5):241-4. No abstract available.

Supplemental Content

Loading ...
Support Center